Cardiology
Scientists in the United States, the United Kingdom and Brazil release new cardiology data
Published in Health Risk Factor Week, June 5th, 2007
Study 1: A new study, "Comparison of the effects of high doses of rosuvastatin versus atorvastatin on the subpopulations of high-density lipoproteins," is now available. According to recent research from the United States, "Atorvastatin and rosuvastatin are both highly effective in decreasing low-density lipoprotein cholesterol and triglyceride levels. However, rosuvastatin was shown to be more effective in increasing high-density lipoprotein (HDL) cholesterol levels."
"The purpose of the study is to compare the effects of daily doses...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Risk Factor Week
More Articles from Health Risk Factor Week
- Aspergillosis
Researchers from Friedrich-Schiller University detail new studies and findings in the area of aspergillosis - Bacterial Meningitis
Investigators at Academic Medical Center, Department of Neurology have published new data on bacterial meningitis - Bird Flu
Wistar Institute Launches New Vaccine Center - Bird Flu Epidemiology
Findings from FAO and National Reference Laboratory for Newcastle Disease and Avian Influenza provide new insights into bird flu epidemiology - Bird Flu Therapy
Findings from Tan Tock Seng Hospital, Department of Infectious Diseases broaden understanding of bird flu therapy - Epidemic
Cigarette Use May Explain Asthma Epidemic in Children - More from this issue of Health Risk Factor Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
